A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone

Clinical trial NCT02066389 · COMPLETED

Trial details

NCT number: NCT02066389
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2014-03-26
Primary completion: 2015-07-02
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.